Dent, S. F. http://orcid.org/0000-0002-9183-9340
Botros, J.
Rushton, M.
Aseyev, O.
Levine, M. N.
Parulekar, W. R.
O’Brien, P.
Burnell, M.
Pritchard, K. I.
Chen, B. E.
Shepherd, L. E.
Funding for this research was provided by:
Canadian Institute for Health Research
Canadian Cancer Society Research Institute
Division of Cancer Epidemiology and Genetics, National Cancer Institute
Article History
Received: 31 January 2020
Accepted: 17 August 2020
First Online: 17 September 2020
Compliance with ethical standards
:
: Susan Dent—advisory board/consulting, honoraria: Pfizer, Novartis, Eli Lilly; research funding Novartis Kathleen I. Pritchard—Advisory board/consulting, honoraria: Pfizer, Roche, Amgen, Novartis, Eisai, Genomic Health Inc., Myriad Genetic Laboratories.